Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

EFAX vs. IDEV: which is better?

Bottom line

EFAX vs IDEV: the short answer

EFAX (State Street(R) SPDR(R) MSCI EAFE Fossil Fuel Reserves Free ETF) and IDEV (iShares Core MSCI International Developed Markets ETF) share a meaningful slice of their top holdings — about 71% by weight.

But IDEV is far broader, holding 2,337 positions to 647 for EFAX, so beyond the top names it adds exposure EFAX doesn't have.

IDEV is cheaper at 0.04% vs 0.2% — a difference of $16 a year per $10,000 invested.

Over five years, EFAX returned +8.4% a year vs +5.0% for IDEV (reporting dates differ).

Updated Nov 19, 2026

EFAX vs IDEV side by side

EFAXIDEV
TypeETFETF
Fund familySPDR (State Street)iShares
CategoryInternational StockInternational Stock
Expense ratio0.2%0.04%
Annual cost per $10k$20$4
10-yr cost on $10k (prospectus)$255$51
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+30.9%+4.5%
5-yr return (annualized)+8.4%+5.0%
10-yr return (annualized)——
Best quarter+16.8%+16.9%
Worst quarter−22.1%−24.0%
Net assets (fund)$502.7M$31.6B
Number of holdings6472,337
Portfolio turnover4%3%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearEFAXIDEVDifference
2024+5.1%+4.5%+0.6%
2023+18.2%+17.3%+0.9%
2022−16.9%−14.9%−1.9%
2021+10.7%+12.7%−2.0%
2020+9.5%+8.4%+1.1%
2019+22.9%+23.4%−0.5%
2018−14.4%−14.3%−0.1%

Source: Fund prospectus bar charts

Holdings overlap

16 of EFAX's top 25 holdings also appear in IDEV's top 25.

Shared top holdings
HoldingEFAXIDEV
ASML Holding NV3.80%2.19%
HSBC Holdings PLC1.62%1.24%
Roche Holding AG1.44%1.05%
Novartis AG1.43%0.98%
AstraZeneca PLC1.41%0.88%
Nestle SA1.32%0.88%
Mitsubishi UFJ Financial Group Inc1.05%0.82%
Banco Santander SA0.98%0.70%
Commonwealth Bank of Australia0.95%0.72%
Allianz SE0.89%0.65%
Schneider Electric SE0.89%0.63%
ABB Ltd0.85%0.53%
Rolls-Royce Holdings PLC0.80%0.57%
Sap Se0.79%0.65%
UBS Group AG0.78%0.57%

Source: SEC Form N-PORT

EFAX top 10

  1. ASML Holding NV — 3.80%
  2. State Street Global Advisors — 2.02%
  3. HSBC Holdings PLC — 1.62%
  4. Roche Holding AG — 1.44%
  5. Novartis AG — 1.43%
  6. AstraZeneca PLC — 1.41%
  7. Nestle SA — 1.32%
  8. Siemens AG — 1.19%
  9. Tokyo Electron Ltd — 1.06%
  10. Mitsubishi UFJ Financial Group Inc — 1.05%

IDEV top 10

  1. ASML Holding N.V. — 2.19%
  2. Hsbc Holdings Plc — 1.24%
  3. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.16%
  4. Roche Holding AG — 1.05%
  5. Royal Bank Of Canada — 1.00%
  6. Novartis AG — 0.98%
  7. Astrazeneca Plc — 0.88%
  8. Nestle S.A. — 0.88%
  9. Shell Plc — 0.88%
  10. Siemens Aktiengesellschaft — 0.83%

FAQ

What is the difference between EFAX and IDEV?
EFAX (State Street(R) SPDR(R) MSCI EAFE Fossil Fuel Reserves Free ETF) and IDEV (iShares Core MSCI International Developed Markets ETF) share a meaningful slice of their top holdings — about 71% by weight. But IDEV is far broader, holding 2,337 positions to 647 for EFAX, so beyond the top names it adds exposure EFAX doesn't have.
Which is cheaper, EFAX or IDEV?
IDEV has the lower expense ratio (0.04%).
Should I own both EFAX and IDEV?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.